A radioisotope (MIBG, iodine-131-meta-iodobenzylguanidine, or iodine-123-meta-iodobenzylguanidine) is injected into a vein. (medlineplus.gov)
I-123 as iobenguane (I-123 meta-iodobenzylguanidine, I-123-MIBG). (e-lactancia.org)
Radioiodine-labeled meta -iodobenzylguanidine (mIBG) is used as a diagnostic agent ( 123 I-mIBG) and a targeted radiotherapy ( 131 I-mIBG) for neuroendocrine cancers. (aspetjournals.org)
SIGNIFICANCE STATEMENT Radiolabeled meta -iodobenzylguanidine (mIBG) has been used as a diagnostic tool and as radiotherapy for neuroendocrine cancers and other diseases. (aspetjournals.org)
Tumor cells1
This compound attaches to specific tumor cells. (medlineplus.gov)
MIBG1
Meta -[ 131 I]iodobenzylguanidine ( 131 I-MIBG) is a radiopharmaceutical for the systemic treatment of patients with metastatic pheochromocytoma and paraganglioma. (springeropen.com)
Diagnostic1
We investigated the diagnostic potentials of 3 MR sequences in identifying and assessing the extent of bone contusion. (cnr.it)
20191
Supplementary MaterialsSupplemental information 1 to 3 41398_2019_536_MOESM1_ESM. (tech-strategy.org)
Days1
You may need to return for repeated scans for 1 to 3 days. (medlineplus.gov)
Properties1
However, the biochemical properties of 211 At and 211 At-labeled compounds have not been clarified owing to the absence of stable astatine isotopes. (springeropen.com)
Hours1
If uncontaminated with I 125: doses up to 20 MBq (0.5 mCi) waiting time= 3 to 6 hours. (e-lactancia.org)
Neuroblastoma3
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells. (duke.edu)
3. Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin αvβ3 Receptors in the Treatment of Neuroblastoma. (nih.gov)
19. Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma cancer stem cells. (nih.gov)
Tumor1
This compound attaches to specific tumor cells. (medlineplus.gov)
Cancer1
A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer. (duke.edu)
Expression1
Finally, MAC was found to trigger apoptotic death pathway (based on expression levels of cleaved-caspase 3, Bax/Bcl-2 balance, p53 and p21). (biomedcentral.com)
Patients1
Of these patients, 3 patients had metastatic HNPGL. (kl.ac.at)